Zacks.com on MSN5 天
MRK's sNDA for Welireg in Rare Tumors Gets FDA's Priority Tag
The FDA accepts and grants priority review to Merck's sNDA for Welireg to treat advanced pheochromocytoma and paraganglioma.
Merck Gets FDA Priority Review of Welireg in Rare Adrenal Tumors
Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...
Nature10 天
Aldosterone-Producing Adenomas And Primary Aldosteronism
Aldosterone-producing adenomas (APAs) are benign tumors of the adrenal glands that lead to ... aspects is crucial for improving diagnosis and treatment options for affected individuals.